EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/357599
3 EW NEWS & OPINION T he World Cornea Congress VII (WCCVII), sponsored by the Cornea Society, will be held this spring in San Diego. The meeting will take place from April 15–17, 2015, immediately preceding the ASCRS•ASOA Symposium & Congress in San Diego. The World Cornea Congress is the Cornea Society's premiere educational and research meeting, highlighting progress and inno- vations in both the clinical and research efforts of the international cornea community. "This is the place to be for cornea specialists," said Christopher J. Rapuano, MD, Wills Eye Hospi- tal, Philadelphia, and president of the Cornea Society. "I think it's the biggest cornea subspecialty meeting that happens any given year. It's where things happen and are dis- cussed, and you can see friends and colleagues from all over the world." The 3-day WCCVII will be- gin with a welcome reception on Wednesday, April 15, followed by the opening ceremony and meeting on Thursday, April 16 and Friday, April 17. The meeting will have concurrent tracks with invited speaker sessions and free paper and poster sessions. The meeting will also have an exhibit hall. Featuring topics including medical cornea, surgical cornea, and basic sciences such as biochemistry and corneal genetics, the meeting should provide a comprehensive learning experience and exciting program for attendees. Specific topics to be discussed will include refractive surgery, infections and inflammation, world health and eye banking, ocular surface disease, corneal tissue engineering, physi- ology and wound healing, corneal transplantation, treatment of ectatic disorders, and more. "It's a very complete cornea meeting," Dr. Rapuano said. The Cornea Society will put out the call for papers and posters and continue planning activities throughout the rest of the year for the meeting. The final program for invited speakers should be available in the fall, and the program for papers and posters will be available early in 2015. The first World Cornea Congress was held in 1964 in Washington, D.C., organized by J. Harry King, MD, according to organizers. Initially held every 10 years, rapid advances in the field, such as innovations in corneal trans- plantation and surgical techniques, prompted the Cornea Society to schedule the congress approximately every 5 years. "Cornea was becoming a much more active field because of all these changes," Dr. Rapuano said. "The world of medicine was changing too, but the field of cornea made great advancements from 15 to 10 to 5 years ago, and continues to make advances." The previous World Cornea Congress, WCCVI, was held in Boston in 2010. Under the leader- ship of Edward Holland, MD, and Mark Mannis, MD, the meeting broke attendance records. With more than 2,000 attendees from around the world, it became one of the largest subspecialty meet- ings held that year, and the Society hopes to continue that trend for the 2015 meeting, Dr. Rapuano said. For more information about the upcoming WCCVII, including housing information and updates, visit the meeting website at corneacongress.org. EW Editors' note: Dr. Rapuano has no financial interests related to his comments. Contact information Rapuano: cjrapuano@willseye.org EyeWorld 8/1/14 Upcoming World Cornea Congress VII promises exciting program by Lauren Lipuma EyeWorld Staff Writer CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: The AcrySof ® IQ posterior chamber intraocular lens is intended for the replacement of the human lens to achieve visual correction of aphakia in adult patients following cataract surgery. This lens is intended for placement in the capsular bag. WARNING/PRECAUTION: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof ® Natural IOL and normal color vision. The effect on vision of the AcrySof ® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS ® or BSS PLUS ® Sterile Intraocular Irrigating Solutions. ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. © 2013 Novartis 2/13 NIQ14041JAD August 2014 April 7-9, 2010 Boston, MA • USA Christopher J. Rapuano, MD April 15–17, 2015 San Diego